Patent · US Active

C-4″ position substituted macrolide derivative

US9139609B2 · kind B2 · utility

0Cited by
11References
6Claims
0Family size

Assignees

Inventors

Key dates

Filing dateFeb 20, 2012
Grant dateSep 22, 2015
Priority date—
Expiry dateFeb 20, 2032

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P31/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A macrolide compound represented by the formula (I) effective against erythromycin resistant bacteria (for example, resistant pneumococci, streptococci and mycoplasmas).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.